Insider Trading July 2, 2026 12:15 PM

J.H. Whitney Equity Partners VII Sells $19.3M in Aveanna Stock Amid Strategic Expansion

Aveanna Healthcare sees credit upgrades and acquisitions as J.H. Whitney reduces stake

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
AVAH

J.H. Whitney Equity Partners VII, LLC, a significant 10% stakeholder in Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), executed a substantial divestment of its common stock holdings on June 30, 2026. The transaction involved the sale of 2,419,035 shares at $8.01 per share, totaling approximately $19.38 million. This sale occurred against a backdrop of positive corporate developments for Aveanna, including a major acquisition and subsequent credit rating upgrades. The transaction highlights the dynamic nature of institutional ownership in the healthcare sector, particularly within the growing home care and pediatric services market.

J.H. Whitney Equity Partners VII Sells $19.3M in Aveanna Stock Amid Strategic Expansion
AVAH
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • J.H. Whitney Equity Partners VII sold 2,419,035 shares of Aveanna Healthcare at $8.01 per share, totaling $19.38 million on June 30, 2026.
  • Aveanna Healthcare completed a $175.5 million cash acquisition of Family First Holding, LLC, expanding its pediatric home care services to 27 locations across seven states.
  • RBC Capital upgraded Aveanna's stock rating to Outperform, and Moody's Ratings raised its corporate family rating from B3 to B2, citing improved business performance and reduced leverage.

J.H. Whitney Equity Partners VII, LLC, a 10% owner of Aveanna Healthcare Holdings, Inc. (NASDAQ:AVAH), disposed of common stock valued at approximately $19.38 million on June 30, 2026. The firm sold 2,419,035 shares at a price of $8.01 per share. The stock has since climbed to $9.29, reflecting a remarkable 98.65% gain over the past year. According to InvestingPro analysis, AVAH remains slightly undervalued with strong momentum, and the platform offers 9 additional ProTips for investors seeking deeper insights into the healthcare company’s prospects.

Following this transaction, J.H. Whitney Equity Partners VII, LLC’s indirect holdings in Aveanna Healthcare Holdings, Inc. include 10,112,123 shares held by J.H. Whitney VII, L.P., 15,523,810 shares held by PSA Healthcare Investment Holdings LLC, and 1,426,034 shares held by PSA Iliad Holdings LLC. The reporting entity directly holds no shares.

J.H. Whitney Equity Partners VII, LLC serves as the general partner for J.H. Whitney VII, L.P. and Whitney Strategic Partners VII, L.P. Whitney Strategic Partners VII, L.P. is the managing member of PSA Healthcare Investment Holdings LLC and PSA Iliad Holdings LLC. As such, J.H. Whitney Equity Partners VII, LLC may be considered to share voting and dispositive power over the shares held by these entities, though it disclaims beneficial ownership beyond its pecuniary interest.

In other recent news, Aveanna Healthcare Holdings Inc. completed its acquisition of Family First Holding, LLC for $175.5 million in cash. This acquisition expands Aveanna’s platform, adding 27 locations across seven states, with a focus on pediatric home care services. Following the acquisition, RBC Capital upgraded Aveanna’s stock rating to Outperform, citing solid execution on preferred payor relationships and the expanded platform scale. Additionally, Moody’s Ratings upgraded Aveanna Healthcare’s corporate family rating to B2 from B3, reflecting improvements in business performance and reduced leverage. The upgrade also included a rise in the company’s senior secured first lien bank credit facility rating and its speculative grade liquidity rating. Aveanna also announced a repricing of its first lien credit facility and revolving credit facility, reducing interest rate margins by 50 basis points. These developments collectively indicate a strengthened financial position and strategic growth for the company.

Risks

  • The divestment by a major 10% owner could signal a shift in institutional confidence or portfolio rebalancing, potentially impacting market sentiment towards the healthcare sector.
  • The successful integration of a $175.5 million acquisition and the execution of preferred payor relationships remain critical for sustaining the positive momentum observed by analysts.

More from Insider Trading

Teradyne Director Mercedes Johnson Executes $76,820 Stock Sale Under Pre-Arranged Plan Jul 2, 2026 PSEG Leadership Divestment: LaRossa Offloads Shares Amid Market Valuation Shifts Jul 2, 2026 Newegg Executives Adjust Holdings as Tech Retailer Integrates AI Jul 2, 2026 Emergent BioSolutions SVP Williams Sells $25,200 in Common Stock Jul 2, 2026 Horace Mann CEO Marita Zuraitis Executes $394,612 Share Sale Under Pre-Arranged Plan Jul 2, 2026